Author:
eczemarelief
Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation – simplywall.st
eczemarelief
February 4, 2026
Phase 2 Data Highlight Roflumilast Cream in Infant AD – Dermatology Times
eczemarelief
February 2, 2026
Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities – simplywall.st
eczemarelief
January 31, 2026
‘Debilitating’: Geelong mother’s uniform struggle for son with eczema – geelongadvertiser.com.au
eczemarelief
January 29, 2026